Published in J Clin Pathol on November 01, 1995
Reversibility of lymphomas and lymphoproliferative lesions developing under cyclosporin-steroid therapy. Lancet (1984) 5.74
Malignant lymphomas in transplantation patients. Transplant Proc (1969) 4.12
The pathology of posttransplant lymphoproliferative disorders occurring in the setting of cyclosporine A-prednisone immunosuppression. Am J Pathol (1988) 3.24
Epstein-Barr virus, immunodeficiency, and B cell lymphoproliferation. Transplantation (1985) 2.34
Epstein-Barr virus infections and DNA hybridization studies in posttransplantation lymphoma and lymphoproliferative lesions: the role of primary infection. J Infect Dis (1985) 1.88
The frequency of Epstein-Barr virus infection and associated lymphoproliferative syndrome after transplantation and its manifestations in children. Transplantation (1988) 1.72
Documentation of Epstein-Barr virus infection in immunodeficient patients with life-threatening lymphoproliferative diseases by Epstein-Barr virus complementary RNA/DNA and viral DNA/DNA hybridization. Cancer Res (1981) 1.72
Tumor incidence in human allograft recipients. Transplant Proc (1979) 1.64
Antigenicity of pooled human malignant and normal tissues by cyto-immunological technique; presence of an insoluble, heat-labile tumor antigen. Int Arch Allergy Appl Immunol (1957) 1.56
Immunosuppression and malignant neoplasms. N Engl J Med (1970) 1.18
Tumors arising in organ transplant recipients. Adv Cancer Res (1978) 1.04
Posttransplant lymphoproliferative disorders in heart-lung transplant recipients: primary presentation in the allograft. Hum Pathol (1989) 0.99
The proliferation marker concept with TPS as a model. A preliminary report. J Nucl Med Allied Sci (1991) 0.79
Rapid detection of octamer binding proteins with 'mini-extracts', prepared from a small number of cells. Nucleic Acids Res (1989) 22.73
Guidelines for the diagnosis and treatment of pulmonary hypertension. Eur Respir J (2009) 6.64
Sequence and analysis of chromosome 4 of the plant Arabidopsis thaliana. Nature (1999) 5.03
OVEC, a versatile system to study transcription in mammalian cells and cell-free extracts. Nucleic Acids Res (1987) 3.56
Markers of bone turnover for the prediction of fracture risk and monitoring of osteoporosis treatment: a need for international reference standards. Osteoporos Int (2010) 3.36
Identification of a novel lymphoid specific octamer binding protein (OTF-2B) by proteolytic clipping bandshift assay (PCBA). EMBO J (1988) 3.33
Treprostinil inhibits the recruitment of bone marrow-derived circulating fibrocytes in chronic hypoxic pulmonary hypertension. Eur Respir J (2010) 2.51
Metastatic non-small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol (2010) 2.49
Statins as antioxidant therapy for preventing cardiac myocyte hypertrophy. J Clin Invest (2001) 2.19
Eukaryotic expression vectors for the analysis of mutant proteins. Nucleic Acids Res (1989) 2.15
Risk factors for chronic thromboembolic pulmonary hypertension. Eur Respir J (2008) 1.97
Drosophila homoeotic genes encode transcriptional activators similar to mammalian OTF-2. Nature (1988) 1.76
Octamer transcription factors bind to two different sequence motifs of the immunoglobulin heavy chain promoter. EMBO J (1989) 1.70
Misreading of termination codons in eukaryotes by natural nonsense suppressor tRNAs. Nucleic Acids Res (2001) 1.68
A heparin-binding protein involved in inhibition of smooth-muscle cell proliferation. Biochem J (1988) 1.59
Expression and function of soluble guanylate cyclase in pulmonary arterial hypertension. Eur Respir J (2008) 1.58
Extracorporeal membrane oxygenation for graft failure after heart transplantation: recent Vienna experience. J Thorac Cardiovasc Surg (2001) 1.52
Rupture and dissection in pulmonary artery aneurysms: incidence, cause, and treatment--review and case report. J Thorac Cardiovasc Surg (2001) 1.49
Local administration of uridine suppresses the cardinal features of asthmatic airway inflammation. Clin Exp Allergy (2010) 1.47
A homeo-box-containing gene expressed during oogenesis in Xenopus. Cell (1984) 1.42
Effects of emotional arousal in the cerebral hemispheres: a study of oscillatory brain activity and event-related potentials. Clin Neurophysiol (2001) 1.40
Blood platelets in cardiopulmonary bypass operations. Recovery occurs after initial stimulation, rather than continual activation. J Thorac Cardiovasc Surg (1989) 1.40
Selective visual-spatial attention alters induced gamma band responses in the human EEG. Clin Neurophysiol (1999) 1.39
Neural drive to the diaphragm after lung volume reduction surgery. Chest (1999) 1.39
Alemtuzumab in lung transplantation: an open-label, randomized, prospective single center study. Am J Transplant (2014) 1.39
Genetic enhancement of fracture repair: healing of an experimental segmental defect by adenoviral transfer of the BMP-2 gene. Gene Ther (2000) 1.39
Alpha-Gal on bioprostheses: xenograft immune response in cardiac surgery. Eur J Clin Invest (2005) 1.38
Measuring extracellular matrix turnover in the serum of patients with idiopathic or ischemic dilated cardiomyopathy and impact on diagnosis and prognosis. Am J Cardiol (1995) 1.34
Behavioral performance follows the time course of neural facilitation and suppression during cued shifts of feature-selective attention. Proc Natl Acad Sci U S A (2010) 1.30
Sodium-volume factor, cardiovascular reactivity and hypotensive mechanism of diuretic therapy in mild hypertension associated with diabetes mellitus. Am J Med (1979) 1.30
Human gamma band activity and perception of a gestalt. J Neurosci (1999) 1.29
The purinergic receptor P2Y2 receptor mediates chemotaxis of dendritic cells and eosinophils in allergic lung inflammation. Allergy (2010) 1.26
Health complaints and immunological markers of exposure to bioaerosols among biowaste collectors and compost workers. Occup Environ Med (2000) 1.25
Perceptual correlates of changes in cortical representation of fingers in blind multifinger Braille readers. J Neurosci (1998) 1.17
Inflammatory response and myocardial injury following coronary artery bypass grafting with or without cardiopulmonary bypass. Eur J Cardiothorac Surg (2000) 1.13
Mathematic modeling of forces associated with shoulder dystocia: a comparison of endogenous and exogenous sources. Am J Obstet Gynecol (2000) 1.13
Failure to detect IL-3-binding sites on human mast cells. J Immunol (1990) 1.10
SNAI transcription factors mediate epithelial-mesenchymal transition in lung fibrosis. Thorax (2009) 1.10
MEG gamma band activity in schizophrenia patients and healthy subjects in a mental arithmetic task and at rest. Clin Neurophysiol (2000) 1.10
Redo lung transplantation: a North American-European experience. J Heart Lung Transplant (1993) 1.08
Postimport methylation of the small subunit of ribulose-1,5-bisphosphate carboxylase in chloroplasts. FEBS Lett (1997) 1.07
[HIV retrospective study of the German Red Cross blood donation service in Germany]. Infusionsther Transfusionsmed (1994) 1.07
Accuracy of echocardiographic right ventricular parameters in patients with different end-stage lung diseases prior to lung transplantation. J Heart Lung Transplant (2000) 1.06
Changed perceptions in Braille readers. Nature (1998) 1.04
Buttressing the staple line in lung volume reduction surgery: a randomized three-center study. Ann Thorac Surg (2000) 1.04
Comparison of data transformation procedures to enhance topographical accuracy in time-series analysis of the human EEG. J Neurosci Methods (2002) 1.04
Clinical ex vivo lung perfusion--pushing the limits. Am J Transplant (2012) 1.04
Recipient vascular endothelial growth factor serum levels predict primary lung graft dysfunction. Am J Transplant (2007) 1.04
T cell senescence and contraction of T cell repertoire diversity in patients with chronic obstructive pulmonary disease. Clin Exp Immunol (2009) 1.03
Recovery from giant cell myocarditis with ECMO support and utilisation of polyclonal antithymocyte globulin: a case report. Thorac Cardiovasc Surg (2006) 1.01
[Free hand acquisition, reconstruction and visualization of 3D and 4D ultrasound]. Radiologe (2000) 1.00
Report of the Xenotransplantation Advisory Committee of the International Society for Heart and Lung Transplantation: the present status of xenotransplantation and its potential role in the treatment of end-stage cardiac and pulmonary diseases. J Heart Lung Transplant (2000) 1.00
Intravenous immunoglobulins induce CD32-mediated platelet aggregation in vitro. Br J Dermatol (2008) 0.99
Pulmonary alveolar microlithiasis: findings on high-resolution CT. AJR Am J Roentgenol (1992) 0.98
Implantation of the Duromedics bileaflet cardiac valve prosthesis in 400 patients. Ann Thorac Surg (1987) 0.96
Modulation of induced gamma band responses and phase synchrony in a paired associate learning task in the human EEG. Neurosci Lett (2001) 0.95
Functional correlates of macroscopic high-frequency brain activity in the human visual system. Neurosci Biobehav Rev (2001) 0.94
Continuous beta-lactam antibiotic therapy in a double-lung transplanted patient with a multidrug-resistant Pseudomonas aeruginosa infection. Transplantation (2001) 0.93
Fate of glyphosate and its influence on nitrogen-cycling in two Finnish agriculture soils. Bull Environ Contam Toxicol (1981) 0.92
Effects of voluntary movements on early auditory brain responses. Exp Brain Res (1996) 0.92
Epidermal growth factor receptor and transforming growth factor alpha expression in human ovarian carcinomas. Eur J Cancer (1992) 0.92
Endothelial cell compatibility of clarithromycin for intravenous use. Clin Biochem (1998) 0.92
Intracellular acidification by inhibition of the Na+/H+-exchanger leads to caspase-independent death of cerebellar granule neurons resembling paraptosis. Cell Death Differ (2004) 0.92
Sustained spatial attention to vibration is mediated in primary somatosensory cortex. Neuroimage (2006) 0.92
Transient left ventricular failure following bilateral lung transplantation for pulmonary hypertension. J Heart Lung Transplant (1999) 0.92
Functional improvement after volume reduction: sternotomy versus videoendoscopic approach. Ann Thorac Surg (1997) 0.91
Midterm results after aortic valve replacement with the autologous tissue cardiac valve. Eur J Cardiothorac Surg (1999) 0.91
Thrombogenic factors are related to urinary albumin excretion rate in type 1 (insulin-dependent) and type 2 (non-insulin-dependent) diabetic patients. Diabetologia (1993) 0.90
Impact of systemic immuno-suppression after solid organ transplantation on allergen-specific responses. Allergy (2010) 0.90
Inter- and intra-individual variation of faecal water - genotoxicity in human colon cells. Mutat Res (2000) 0.90
Norepinephrine clearance and pressor effect in normal and hypertensive man. Klin Wochenschr (1980) 0.90
The differential ability of IL-8 and neutrophil-activating peptide-2 to induce attenuation of chemotaxis is mediated by their divergent capabilities to phosphorylate CXCR2 (IL-8 receptor B). J Immunol (1997) 0.90
Independent prognostic role of p16 expression in lung cancer. J Thorac Cardiovasc Surg (1999) 0.89
No increased prevalence of the factor V Leiden mutation in chronic major vessel thromboembolic pulmonary hypertension (CTEPH) Thromb Haemost (1996) 0.89
Differential expression of cell surface integrins on human mast cells and human basophils. Ann Hematol (1992) 0.89
In vitro effects of mycophenolic acid on the nucleotide pool and on the expression of adhesion molecules of human umbilical vein endothelial cells. Clin Chim Acta (2001) 0.89
Four year follow-up of the Duromedics Edwards bileaflet valve prostheses. J Cardiovasc Surg (Torino) (1990) 0.89
Treprostinil for severe inoperable chronic thromboembolic pulmonary hypertension. J Thromb Haemost (2007) 0.89
Cardiopulmonary bypass affects cognitive brain function after coronary artery bypass grafting. Ann Thorac Surg (2001) 0.89
Energy consumption in paraplegic ambulation using the reciprocating gait orthosis and electric stimulation of the thigh muscles. Arch Phys Med Rehabil (1990) 0.89
Pulmonary and aortic blood flow measurements in normal subjects and patients after single lung transplantation at 0.5 T using velocity encoded cine MRI. Chest (1998) 0.88
Pulmonary retransplantation: predictors of graft function and survival in 230 patients. Pulmonary Retransplant Registry. Ann Thorac Surg (1998) 0.88
Glycosylated haemoglobin in renal failure. Diabetologia (1980) 0.88
The use of bioluminescence to evaluate the influence of chemotherapeutic drugs on ATP-levels of malignant cell lines. J Clin Chem Clin Biochem (1986) 0.88
Inhibition of tyrosine kinase activation blocks the down-regulation of CXC chemokine receptor 4 by HIV-1 gp120 in CD4+ T cells. J Immunol (1999) 0.88
Endovascular stent graft repair for aneurysms on the descending thoracic aorta. Ann Thorac Surg (1998) 0.88
In vitro effects of mycophenolic acid on cell cycle and activation of human lymphocytes. Clin Chim Acta (2000) 0.88
NPY/Y₁ receptor-mediated vasoconstrictory and proliferative effects in pulmonary hypertension. Br J Pharmacol (2014) 0.88
Metal ion-induced toxic histamine release from human basophils and mast cells. J Biomed Mater Res (1998) 0.88
Serum matrix metalloprotease-1 and vascular endothelial growth factor--a predict cardiac allograft rejection. Am J Transplant (2008) 0.88
[Survival, clinical data and quality of life 10 years after heart transplantation: a prospective study]. Z Kardiol (2002) 0.87
Results of open heart surgery in Jehovah's Witnesses patients. J Cardiovasc Surg (Torino) (2009) 0.87
Successful lung transplantation for bronchiolitis obliterans after allogeneic marrow transplantation. Transplantation (2001) 0.87
The pulmonary nodule after lung transplantation. Cause and outcome. Chest (1995) 0.87
Transitional cell carcinoma of the bladder with solitary metastasis to the penis 4 years after successful heart transplantation. A case report and review of the literature. Transplantation (1994) 0.87
Progressive familial intrahepatic cholestasis types 1, 2, and 3. Gut (1998) 0.87
Plaque ablation by excimer laser irradiation using a movable energy-transmitting device. Tex Heart Inst J (1987) 0.86
Impact of glutaraldehyde on calcification of pericardial bioprosthetic heart valve material. Ann Thorac Surg (1996) 0.86